🟢 Amdocs is trading 5% up today after fiscal Q3 results met guidance midpoint

Amdocs is trading 5% up now at $58.14 after fiscal third-quarter results released August 5, 2026, met the midpoint of revenue and non-GAAP EPS guidance.

• Revenue increased 2.7% year over year to approximately $1.175 billion, while non-GAAP EPS reached $1.84.
• Management reaffirmed approximately 3% constant-currency revenue growth and 6% non-GAAP EPS growth for fiscal 2026.
• The company also highlighted ten aOS customer engagements and a major Liberty Latin America transformation win.